Incidence, predictors, and treatment outcomes of biphasic anaphylaxis in the emergency department of a tertiary hospital:A 5-year retrospective study.

IF 2.3 4区医学 Q3 ALLERGY

Asian Pacific journal of allergy and immunology Pub Date : 2024-04-20 DOI:10.12932/ap-101223-1745

Waratchaya Uawattanasakul, Ploylarp Lertvipapath, Thanachit Krikeerati, Chamard Wongsa, Torpong Thongngarm, Mongkhon Sompornrattanaphan

引用次数: 0

Abstract

Biphasic anaphylaxis despite successful treatment has an incidence of 4-5% based on NIAID/FAAN criteria. Our study aimed to investigate the frequency and predictive factors associated with biphasic reactions within the emergency department (ED) at Siriraj Hospital.

查看原文本刊更多论文

一家三级医院急诊科双相过敏性休克的发病率、预测因素和治疗结果：一项为期 5 年的回顾性研究。

根据 NIAID/FAAN 标准，在成功治疗后仍出现双相过敏性休克的发生率为 4-5%。我们的研究旨在调查西里拉吉医院急诊科（ED）中双相过敏反应的发生频率和相关预测因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Pacific journal of allergy and immunology 医学-过敏

CiteScore

12.80

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The Asian Pacific Journal of Allergy and Immunology (APJAI) is an online open access journal with the recent impact factor (2018) 1.747 APJAI published 4 times per annum (March, June, September, December). Four issues constitute one volume. APJAI publishes original research articles of basic science, clinical science and reviews on various aspects of allergy and immunology. This journal is an official journal of and published by the Allergy, Asthma and Immunology Association, Thailand. The scopes include mechanism, pathogenesis, host-pathogen interaction, host-environment interaction, allergic diseases, immune-mediated diseases, epidemiology, diagnosis, treatment and prevention, immunotherapy, and vaccine. All papers are published in English and are refereed to international standards.